615 related articles for article (PubMed ID: 10428060)
1. Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.
King PJ; Widdowson PS; Doods HN; Williams G
J Neurochem; 1999 Aug; 73(2):641-6. PubMed ID: 10428060
[TBL] [Abstract][Full Text] [Related]
2. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
Silva AP; Carvalho AP; Carvalho CM; Malva JO
Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
[TBL] [Abstract][Full Text] [Related]
3. K(+)-Evoked [(3)H]D-aspartate release in rat spinal cord synaptosomes: modulation by neuropeptide Y and calcium channel antagonists.
Martire M; Altobelli D; Maurizi S; Preziosi P; Fuxe K
J Neurosci Res; 2000 Dec; 62(5):722-9. PubMed ID: 11104511
[TBL] [Abstract][Full Text] [Related]
4. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
Wang SJ
Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y release in the rat spinal cord measured with Y1 receptor internalization is increased after nerve injury.
Marvizon JC; Chen W; Fu W; Taylor BK
Neuropharmacology; 2019 Nov; 158():107732. PubMed ID: 31377198
[TBL] [Abstract][Full Text] [Related]
6. NPY receptor subtype in the rabbit isolated ileum.
Félétou M; Nicolas JP; Rodriguez M; Beauverger P; Galizzi JP; Boutin JA; Duhault J
Br J Pharmacol; 1999 Jun; 127(3):795-801. PubMed ID: 10401572
[TBL] [Abstract][Full Text] [Related]
7. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
Widdowson PS
Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
[TBL] [Abstract][Full Text] [Related]
8. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.
Dumont Y; Gaudreau P; Mazzuferi M; Langlois D; Chabot JG; Fournier A; Simonato M; Quirion R
Br J Pharmacol; 2005 Dec; 146(8):1069-81. PubMed ID: 16231000
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
10. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
11. Omega-conotoxin- and nifedipine-insensitive voltage-operated calcium channels mediate K(+)-induced release of pro-thyrotropin-releasing hormone-connecting peptides Ps4 and Ps5 from perifused rat hypothalamic slices.
Valentijn K; Tranchand Bunel D; Vaudry H
Brain Res Mol Brain Res; 1992 Jul; 14(3):221-30. PubMed ID: 1331651
[TBL] [Abstract][Full Text] [Related]
12. The use of invertebrate peptide toxins to establish Ca2+ channel identity of CA3-CA1 neurotransmission in rat hippocampal slices.
Nooney JM; Lodge D
Eur J Pharmacol; 1996 Jun; 306(1-3):41-50. PubMed ID: 8813613
[TBL] [Abstract][Full Text] [Related]
13. Modulation of potassium-evoked [3H]dopamine release from rat striatal slices by voltage-activated calcium channel ligands: effects of omega-conotoxin-MVIIC.
Dobrev D; Andreas K
Neurochem Res; 1997 Sep; 22(9):1085-93. PubMed ID: 9251097
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor?
Haynes AC; Arch JR; Wilson S; McClue S; Buckingham RE
Regul Pept; 1998 Sep; 75-76():355-61. PubMed ID: 9802429
[TBL] [Abstract][Full Text] [Related]
15. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
Widdowson PS; Buckingham R; Williams G
Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
[TBL] [Abstract][Full Text] [Related]
16. Involvement of P-type calcium channels in high potassium-elicited release of neurotransmitters from rat brain slices.
Kimura M; Yamanishi Y; Hanada T; Kagaya T; Kuwada M; Watanabe T; Katayama K; Nishizawa Y
Neuroscience; 1995 Jun; 66(3):609-15. PubMed ID: 7644024
[TBL] [Abstract][Full Text] [Related]
17. Effects of N-, P- and Q-type neuronal calcium channel antagonists on mammalian peripheral neurotransmission.
Wright CE; Angus JA
Br J Pharmacol; 1996 Sep; 119(1):49-56. PubMed ID: 8872356
[TBL] [Abstract][Full Text] [Related]
18. Nerve injury increases an excitatory action of neuropeptide Y and Y2-agonists on dorsal root ganglion neurons.
Abdulla FA; Smith PA
Neuroscience; 1999 Mar; 89(1):43-60. PubMed ID: 10051216
[TBL] [Abstract][Full Text] [Related]
19. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors.
Jain MR; Pu S; Kalra PS; Kalra SP
Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146
[TBL] [Abstract][Full Text] [Related]
20. Distinct effects of omega-toxins and various groups of Ca(2+)-entry inhibitors on nicotinic acetylcholine receptor and Ca2+ channels of chromaffin cells.
Villarroya M; De la Fuente MT; López MG; Gandía L; García AG
Eur J Pharmacol; 1997 Feb; 320(2-3):249-57. PubMed ID: 9059861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
